Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Disorder

Danielle Hett, Steven Marwaha, Danielle Hett, Steven Marwaha

Abstract

Bipolar disorder (BD) is a debilitating mood disorder marked by manic, hypomanic and/or mixed or depressive episodes. It affects approximately 1-2% of the population and is linked to high rates of suicide, functional impairment and poorer quality of life. Presently, treatment options for BD are limited. There is a strong evidence base for pharmacological (e.g., lithium) and psychological (e.g., psychoeducation) treatments; however, both of these pose challenges for treatment outcomes (e.g., non-response, side-effects, limited access). Repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, is a recommended treatment for unipolar depression, but it is unclear whether rTMS is an effective, safe and well tolerated treatment in people with BD. This article reviews the extant literature on the use of rTMS to treat BD across different mood states. We found 34 studies in total (N = 611 patients), with most assessing bipolar depression (n = 26), versus bipolar mania (n = 5), mixed state bipolar (n = 2) or those not in a current affective episode (n = 1). Across all studies, there appears to be a detectable signal of efficacy for rTMS treatment, as most studies report that rTMS treatment reduced bipolar symptoms. Importantly, within the randomised controlled trial (RCT) study designs, most reported that rTMS was not superior to sham in the treatment of bipolar depression. However, these RCTs are based on small samples (NBD ⩽ 52). Reported side effects of rTMS in BD include headache, dizziness and sleep problems. Ten studies (N = 14 patients) reported cases of affective switching; however, no clear pattern of potential risk factors for affective switching emerged. Future adequately powered, sham-controlled trials are needed to establish the ideal rTMS treatment parameters to help better determine the efficacy of rTMS for the treatment of BD.

Keywords: bipolar disorder; depression; mania; rTMS; repetitive transcranial magnetic stimulation; treatment.

Conflict of interest statement

Conflict of interest statement: Steven Marwaha has attended educational events sponsored by Sunovion, Janssen and Lundbeck

© The Author(s), 2020.

Figures

Figure 1.
Figure 1.
Systematic review process: PRISMA diagram. PRISMA, preferred reporting items for systematic reviews and meta-analyses; rTMS, repetitive transcranial magnetic stimulation; TMS, transcranial magnetic stimulation.

References

    1. Goodwin FK, Jamison KR. Manic-depressive illness: bipolar disorders and recurrent depression. New York: Oxford University Press, 2007.
    1. Strejilevich S, Martino DJ, Murru A, et al. Mood instability and functional recovery in bipolar disorders. Acta Psychiatr Scand 2013; 128: 194–202.
    1. Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol 2018; 8: 251–269.
    1. Pini S, de Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 2005; 15: 425–434.
    1. van der Voort TY, van Meijel B, Hoogendoorn AW, et al. Collaborative care for patients with bipolar disorder: effects on functioning and quality of life. J Affect Disord 2015; 179: 14–22.
    1. Marwaha S, Durrani A, Singh S. Employment outcomes in people with bipolar disorder: a systematic review. Acta Psychiatr Scand 2013; 128: 179–193.
    1. Baldessarini RJ, Tondo L, Pinna M, et al. Suicidal risk factors in major affective disorders. Br J Psychiatry 2019; 215: 621–626.
    1. Solomon DA, Keitner GI, Miller IW, et al. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 1995; 56: 5–13.
    1. Fountoulakis KN, Grunze H, Vieta E, et al. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines. Int J Neuropsychopharmacol 2017; 20: 180–195.
    1. Kemp DE. Managing the side effects associated with commonly used treatments for bipolar depression. J Affect Disord 2014; 169(Suppl. 1): S34–S44.
    1. Keck PE, Jr, McElroy SL. Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 1996; 16(2 Suppl. 1): 15S–23S.
    1. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 2002; 159: 1927–1929.
    1. Miasso AI, Carmo BPD, Tirapelli CR. Bipolar affective disorder: pharmacotherapeutic profile and adherence to medication. Rev Esc Enferm USP 2012; 46: 689–695.
    1. El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial. J Affect Disord 2015; 184: 318–321.
    1. Gitlin MJ. Antidepressants in bipolar depression: an enduring controversy. Int J Bipolar Disord 2018; 17: 278–283.
    1. Tohen M, Frank E, Bowden CL, et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009; 11: 453–473.
    1. Sidor MM, MacQueen GM. An update on antidepressant use in bipolar depression. Curr Psychiatry Rep 2012; 14: 696–704.
    1. McGirr A, Karmani S, Arsappa R, et al. Clinical efficacy and safety of repetitive transcranial magnetic stimulation in acute bipolar depression. World Psychiatry 2016; 15: 85–86.
    1. McGirr A, Vöhringer PA, Ghaemi SN, et al. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry 2016; 3: 1138–1146.
    1. Vázquez GH, Tondo L, Undurraga J, et al. Overview of antidepressant treatment of bipolar depression. Int J Neuropsychopharmacol 2013; 16: 1673–1685.
    1. Swartz HA, Swanson J. Psychotherapy for bipolar disorder in adults: a review of the evidence. Focus 2014; 12: 251–266.
    1. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013; 381: 1672–1682.
    1. Reinares M, Sanchez-Moreno J, Fountoulakis KN. Psychosocial interventions in bipolar disorder: what, for whom, and when. J Affect Disord 2014; 156: 46–55.
    1. Pandya M, Altinay M, Malone DA, et al. Where in the brain is depression? Curr Psychiatry Rep 2012; 14: 634–642.
    1. Mishra BR, Sarkar S, Praharaj SK, et al. Repetitive transcranial magnetic stimulation in psychiatry. Ann Indian Acad Neurol 2011; 14: 245–251.
    1. Banerjee J, Sorrell ME, Celnik PA, et al. Immediate effects of repetitive magnetic stimulation on single cortical pyramidal neurons. PLoS One 2017; 12: e0170528.
    1. Wassermann EM, Lisanby SH. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 2001; 112: 1367–1377.
    1. Mendlowitz AB, Shanbour A, Downar J, et al. Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: a cost analysis. PLoS One 2019; 14: e0222546.
    1. Slotema CW, Dirk Blom J, Hoek HW, et al. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 2010; 71: 873–874.
    1. Hett D, Rogers J, Humpston C, et al. Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in adolescence: a systematic review. J Affect Disord 2020; 278: 460–469.
    1. Croarkin PE, MacMaster FP. Transcranial magnetic stimulation for adolescent depression. Child Adolesc Psychiatr Clin N Am 2019; 28: 33–43.
    1. Magavi LR, Reti IM, Vasa RA. A review of repetitive transcranial magnetic stimulation for adolescents with treatment-resistant depression. Int Rev Psychiatry 2017; 29: 79–88.
    1. Teng S, Guo Z, Peng H, et al. High-frequency repetitive transcranial magnetic stimulation over the left DLPFC for major depression: session-dependent efficacy: a meta-analysis. Eur Psychiatry 2017; 41: 75–84.
    1. Xia G, Gajwani P, Muzina DJ, et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol 2008; 11: 119–130.
    1. Gold AK, Ornelas AC, Cirillo P, et al. Clinical applications of transcranial magnetic stimulation in bipolar disorder. Brain Behav 2019; 9: e01419.
    1. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56.
    1. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382–389.
    1. Beck AT, Steer RA, Brown GK. BDI-II: Beck Depression Inventory (2nd ed.). San Antonio, TX: The Psychological Corporation, 1996.
    1. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573–583.
    1. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429–435.
    1. Garcia-Toro M. Acute manic symptomatology during repetitive transcranial magnetic stimulation in a patient with bipolar depression. Br J Psychiatry 1999; 175: 491–491.
    1. Dolberg OT, Schreiber S, Grunhaus L. Transcranial magnetic stimulation-induced switch into mania: a report of two cases. Biol Psychiatry 2001; 49: 468–470.
    1. Hausmann A, Kramer-Reinstadler K, Lechner-Schoner T, et al. Can bilateral prefrontal repetitive transcranial magnetic stimulation (rTMS) induce mania? A case report. J Clin Psychiatry 2004; 65: 1575–1576.
    1. Li X, Fryml L, Rodriguez JJ, et al. Safe management of a bipolar depressed patient with prefrontal repetitive transcranial magnetic stimulation (rTMS) over 7 years and >2 million stimuli. Brain Stimul 2014; 7: 919–921.
    1. Zendjidjian XY, Lodovighi MA, Richieri R, et al. Resistant bipolar depressive disorder: case analysis of adjunctive transcranial magnetic stimulation efficiency in medical comorbid conditions. Bipolar Disord 2014; 16: 211–213.
    1. Brunelin J, Maklouf WB, Nicolas A, et al. Successful switch to maintenance rTMS after maintenance ECT in refractory bipolar disorder. Brain Stimul 2010; 4: 238–239.
    1. Huang CC, Su TP, Shan IK. A case report of repetitive transcranial magnetic stimulation-induced mania. Bipolar Disord 2004; 6: 444–445.
    1. Kaster TS, Knyahnytska Y, Noda Y, et al. Treatment-emergent mania with psychosis in bipolar depression with left intermittent theta-burst rTMS. Brain Stimul 2020; 13: 705–706.
    1. Cohen RB, Brunoni AR, Boggio PS, et al. Clinical predictors associated with duration of repetitive transcranial magnetic stimulation treatment for remission in bipolar depression: a naturalistic study. J Nerv Ment Dis 2010; 198: 679–681.
    1. Carnell BL, Clarke P, Gill S, et al. How effective is repetitive transcranial magnetic stimulation for bipolar depression? J Affect Disord 2017; 209: 270–272.
    1. Phillips AL, Burr RL, Dunner DL. Repetitive transcranial magnetic stimulation in the treatment of bipolar depression: experience from a clinical setting. J Psychiatr Pract 2020; 26: 37–45.
    1. Dell’Osso B, Mundo E, D’Urso N, et al. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord 2009; 11: 76–81.
    1. Dell’Osso B, D’Urso N, Castellano F, et al. Long-term efficacy after acute augmentative repetitive transcranial magnetic stimulation in bipolar depression: a 1-year follow-up study. J ECT 2011; 27: 141–144.
    1. Kazemi R, Rostami R, Khomami S, et al. Bilateral transcranial magnetic stimulation on DLPFC changes resting state networks and cognitive function in patients with bipolar depression. Front Hum Neurosci 2018; 12: 356.
    1. Fitzgerald PB, Huntsman S, Gunewardene R, et al. A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression. Int J Neuropsychopharmacol 2006; 9: 655–666.
    1. Dell’Osso B, Oldani L, Camuri G, et al. Augmentative repetitive Transcranial Magnetic Stimulation (rTMS) in the acute treatment of poor responder depressed patients: a comparison study between high and low frequency stimulation. Eur Psychiatry 2015; 30: 271–276.
    1. Kazemi R, Rostami R, Khomami S, et al. Electrophysiological correlates of bilateral and unilateral repetitive transcranial magnetic stimulation in patients with bipolar depression. Psychiatry Res 2016; 240: 364–375.
    1. Dolberg O, Dannon P, Schreiber S, et al. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord 2002; 4: 94–95.
    1. Nahas Z, Kozel FA, Li X, et al. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord 2003; 5: 40–47.
    1. Fitzgerald PB, Benitez J, de Castella A, et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006; 163: 88–94.
    1. Tamas RL, Menkes D, El-Mallakh RS. Stimulating research: a prospective, randomized, double-blind, sham-controlled study of slow transcranial magnetic stimulation in depressed bipolar patients. J Neuropsychiatry Clin Neurosci 2007; 19: 198–199.
    1. Beynel L, Chauvin A, Guyader N, et al. What saccadic eye movements tell us about TMS-induced neuromodulation of the DLPFC and mood changes: a pilot study in bipolar disorders. Front Integr Neurosci 2014; 8: 65.
    1. Hu S-H, Lai J-B, Xu D-R, et al. Efficacy of repetitive transcranial magnetic stimulation with quetiapine in treating bipolar II depression: a randomized, double-blinded, control study. Sci Rep 2016; 6: 1–7.
    1. Fitzgerald PB, Hoy KE, Elliot D, et al. A negative double-blind controlled trial of sequential bilateral rTMS in the treatment of bipolar depression. J Affect Disord 2016; 198: 158–162.
    1. Yang L-L, Zhao D, Kong L-L, et al. High-frequency repetitive transcranial magnetic stimulation (rTMS) improves neurocognitive function in bipolar disorder. J Affect Disord 2019; 246: 851–856.
    1. Bulteau S, Beynel L, Marendaz C, et al. Twice-daily neuronavigated intermittent theta burst stimulation for bipolar depression: a randomized sham-controlled pilot study. Neurophysiol Clin 2019; 49: 371–375.
    1. Michael N, Erfurth A. Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. J Affect Disord 2004; 78: 253–257.
    1. Saba G, Rocamora JF, Kalalou K, et al. Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: a case series of eight patients. Psychiatry Res 2004; 128: 199–202.
    1. Grisaru N, Chudakov B, Yaroslavsky Y, et al. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry 1998; 155: 1608–1610.
    1. Kaptsan A, Yaroslavsky Y, Applebaum J, et al. Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord 2003; 5: 36–39.
    1. Praharaj SK, Ram D, Arora M. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: a randomized sham controlled study. J Affect Disord 2009; 117: 146–150.
    1. Zeeuws D, De Rycker K, De Raedt R, et al. Intensive high-frequency repetitive transcranial magnetic stimulation treatment in an electroconvulsive shock therapy-resistant bipolar I patient with mixed episode. Brain Stimul 2011; 4: 46–49.
    1. Pallanti S, Grassi G, Antonini S, et al. rTMS in resistant mixed states: an exploratory study. J Affect Disord 2014; 157: 66–71.
    1. Li X, Nahas Z, Anderson B, et al. Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety 2004; 20: 98–100.
    1. Galletly C, Gill S, Clarke P, et al. A randomized trial comparing repetitive transcranial magnetic stimulation given 3 days/week and 5 days/week for the treatment of major depression: is efficacy related to the duration of treatment or the number of treatments? Psychol Med 2012; 42: 981–988.
    1. Galletly CA, Clarke P, Carnell BL, et al. A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on. Aust N Z J Psychiatry 2015; 49: 1040–1047.
    1. Bech P, Rafaelsen O, Kramp P, et al. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978; 17: 430–431.
    1. Rachid F. Repetitive transcranial magnetic stimulation and treatment-emergent mania and hypomania: a review of the literature. J Psychiatr Pract 2017; 23: 150–159.
    1. Berlim MT, Van den Eynde F, Daskalakis ZJ. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013; 38: 543–551.
    1. Gaynes BN, Lloyd SW, Lux L, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry 2014; 75: 477–489.
    1. Rossi S, Hallett M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120: 2008–2039.
    1. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008; 11: 131–147.
    1. Kar SK. Predictors of response to repetitive transcranial magnetic stimulation in depression: a review of recent updates. Clin Psychopharmacol Neurosci 2019; 17: 25–33.
    1. Zhengwu P, Cuihong Z, Shanshan X, et al. Mechanism of repetitive transcranial magnetic stimulation for depression. Shanghai Arch Psychiatry 2018; 30: 84–92.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner